He serves as a consultant, advisory board member, or has received honoraria from Alder, Allergan, Amgen, American Headache Society, Autonomic Technologies, Avanir, Dr. Reddy's Laboratories/Promius Pharma, Eli Lilly and Company, Ipsen Biosciences, Nocira, Novartis, and Teva.
He has reviewed for the NIA and NINDS, serves as consultant, advisory board member, or has received honoraria from: Alder, Allergan, Amgen, Autonomic Technologies, Avanir, Boston Scientific, Colucid, Dr. Reddy's, Electrocore, Eli Lilly, eNeura Therapeutics, GlaxoSmithKline, Merck, Pfizer, Teva, and Vedanta.
Dr. Green has relationships with Alvine (consultant, advisory committee), Alba Therapeutics (advisory committee).
David Johnson has served on the consultant advisory boards for Genzyme (manufacturer of sevelamer) and Amgen (manufacturer of cinacalcet).
JB is a consultant, advisory board memeber and a speaker for Janssen Cilag BV, Eli Lilly, Bristol-Myer Squibb, UCB, Shire, Medice and Pfizer.
MJD has acted as consultant, advisory board member and speaker for Novartis, Novo Nordisk, Sanofi-Aventis, Lilly, Merck Sharp & Dohme and Roche, and as a speaker for Servier.
(consultant), Eli Lilly (advisory board, consultant, speaker), Johnson & Johnson (consultant), Lundbeck (consultant), Memory Pharmaceuticals (advisory board, consultant), Merck (advisory board, consultant), Orexigen (consultant), Organon (advisory board), Pfizer (consultant), Sanofi/Aventis (advisory board, consultant), Shering-Plough (consultant), Wyeth (consultant), and Xenoport (consultant).
Sait Ashina, MD, has served a consultant on advisory board for NeurogesX and Depomed.
Terrence Karner, a 43-year-old consultant with advisory firm Deloitte in Chicago, is in the middle of a six-month placement with his firm's New York office to pursue better opportunities.
Author TT – Consultant or Advisory Role; Schering.
Consultant or advisory role for AstraZeneca (JVH, BEJ, AJR).
